ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

FDA: Oncology Division Director Delap Promoted In Agency

May 29, 1998

Bill Pressures HCFA To Launch Project On Reimbursement for Cancer Trials

July 26, 1996

ACS to Purchase $1.5 Million In animal Interferon, Offer it for Laboratory Studies

July 13, 1984

IARC Director Denies NCI Staff Interference With Monograph

May 28, 1982

Key Hearings Scheduled On Cancer Act, Appropriations

January 21, 1977

DeVita Says NCAB Subcommittee’s Recommendation For Reshaping Organ Site Program Is “Reasonable”

April 23, 1982